Company · Healthtech & Bio

Iteria Biopharma

iteriabiopharma.com ↗ ·A Coruña ·Seed

Spanish biopharmaceutical company founded in 2024 (spun out of GalChimia) that discovers and develops first-in-class precision drugs for hard-to-treat, treatment-resistant cancers, with a lead program (ITR-251) targeting metastatic castration-resistant prostate cancer plus programs in pancreatic, colorectal and lung cancer. Closed a €5M Series Seed round in April 2026 led by Inveready with Xesgalicia and the founding partners.

Founded
2024
Founders
3
News
0
Rounds
1
Investors
2
SectorsOncology, Biopharmaceuticals, Drug Discovery Start-up MapHealthtech & Bio › Drug discovery & therapeutics developers

Profile updated 2 Aug 2026

Founders

Carme Pampín
Co-Founder (also CEO of GalChimia)
Julio Castro
Co-Founder (also CEO of Palobiofarma)
Ramon Bosser
CEO & Co-Founder

Global models

No comparables on record yet.

Investors 2

Inveready
inveready.com
Investor Spain
Xesgalicia
www.xesgalicia.gal/en
Investor Spain

Funding rounds 1

Seed · €5M
Iteria Biopharma, a GalChimia spin-out developing treatments for advanced metastatic cancers, closed a €5M seed round led by Inveready throu…
2026-04-16

News & media

No coverage on record yet.
Start typing to search across everything.
↑↓ navigate↵ openesc close